Cargando…
Effect of diabetes type on long‐term outcome of epidermal axon regeneration
OBJECTIVE: To assess the effect of diabetes type on the long‐term rate and extent of epidermal nerve regeneration. METHODS: Subjects with well controlled type 1 diabetes mellitus (n = 11) or type 2 diabetes mellitus (n = 36), with normal nerve conduction studies and baseline intraepidermal nerve fib...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801164/ https://www.ncbi.nlm.nih.gov/pubmed/31560176 http://dx.doi.org/10.1002/acn3.50904 |
_version_ | 1783460524837568512 |
---|---|
author | Khoshnoodi, Mohammad Truelove, Shaun Polydefkis, Michael |
author_facet | Khoshnoodi, Mohammad Truelove, Shaun Polydefkis, Michael |
author_sort | Khoshnoodi, Mohammad |
collection | PubMed |
description | OBJECTIVE: To assess the effect of diabetes type on the long‐term rate and extent of epidermal nerve regeneration. METHODS: Subjects with well controlled type 1 diabetes mellitus (n = 11) or type 2 diabetes mellitus (n = 36), with normal nerve conduction studies and baseline intraepidermal nerve fiber density (IENFD), and healthy controls (n = 10) underwent chemical axotomy of the intraepidermal nerves at the thigh using topical capsaicin. Skin biopsies were performed at 30, 90, 150, and 180 days post‐axotomy. RESULTS: After 180 days, IENFD in diabetic subjects remained significantly below baseline levels, while healthy controls returned to normal. At each time point, regeneration rates were significantly slower among diabetic subjects, although type 1 subjects regenerated significantly faster and achieved higher percentages of baseline IENFD compared with type 2. INTERPRETATION: Among diabetic patients, nerve injury recovery is likely to take significantly longer than in healthy individuals, and remains incomplete, particularly among type 2 patients. This may partially explain the progression of neuropathy among diabetic patients: damage accumulates because nerve recovery is slowed and incomplete. Furthermore, these findings support caution when recommending certain procedures, such as carpal tunnel repair, to patients with progressed diabetic disease. |
format | Online Article Text |
id | pubmed-6801164 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68011642019-10-22 Effect of diabetes type on long‐term outcome of epidermal axon regeneration Khoshnoodi, Mohammad Truelove, Shaun Polydefkis, Michael Ann Clin Transl Neurol Research Articles OBJECTIVE: To assess the effect of diabetes type on the long‐term rate and extent of epidermal nerve regeneration. METHODS: Subjects with well controlled type 1 diabetes mellitus (n = 11) or type 2 diabetes mellitus (n = 36), with normal nerve conduction studies and baseline intraepidermal nerve fiber density (IENFD), and healthy controls (n = 10) underwent chemical axotomy of the intraepidermal nerves at the thigh using topical capsaicin. Skin biopsies were performed at 30, 90, 150, and 180 days post‐axotomy. RESULTS: After 180 days, IENFD in diabetic subjects remained significantly below baseline levels, while healthy controls returned to normal. At each time point, regeneration rates were significantly slower among diabetic subjects, although type 1 subjects regenerated significantly faster and achieved higher percentages of baseline IENFD compared with type 2. INTERPRETATION: Among diabetic patients, nerve injury recovery is likely to take significantly longer than in healthy individuals, and remains incomplete, particularly among type 2 patients. This may partially explain the progression of neuropathy among diabetic patients: damage accumulates because nerve recovery is slowed and incomplete. Furthermore, these findings support caution when recommending certain procedures, such as carpal tunnel repair, to patients with progressed diabetic disease. John Wiley and Sons Inc. 2019-09-27 /pmc/articles/PMC6801164/ /pubmed/31560176 http://dx.doi.org/10.1002/acn3.50904 Text en © 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Articles Khoshnoodi, Mohammad Truelove, Shaun Polydefkis, Michael Effect of diabetes type on long‐term outcome of epidermal axon regeneration |
title | Effect of diabetes type on long‐term outcome of epidermal axon regeneration |
title_full | Effect of diabetes type on long‐term outcome of epidermal axon regeneration |
title_fullStr | Effect of diabetes type on long‐term outcome of epidermal axon regeneration |
title_full_unstemmed | Effect of diabetes type on long‐term outcome of epidermal axon regeneration |
title_short | Effect of diabetes type on long‐term outcome of epidermal axon regeneration |
title_sort | effect of diabetes type on long‐term outcome of epidermal axon regeneration |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801164/ https://www.ncbi.nlm.nih.gov/pubmed/31560176 http://dx.doi.org/10.1002/acn3.50904 |
work_keys_str_mv | AT khoshnoodimohammad effectofdiabetestypeonlongtermoutcomeofepidermalaxonregeneration AT trueloveshaun effectofdiabetestypeonlongtermoutcomeofepidermalaxonregeneration AT polydefkismichael effectofdiabetestypeonlongtermoutcomeofepidermalaxonregeneration |